Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedApr 04, 2026
DataAggregated Company Financials
Companies23
- 7D9.5%
- 3M-5.6%
- 1Y383.5%
- YTDn/a
In the last week, the Biotech industry is up 5.7%, with ABIVAX Société Anonyme up 7.0%. In the same time, Inventiva was down 8.3%. This means that the industry has gained 322% over the past year. Looking forward, earnings are forecast to grow by 56% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Apr 2026 | €12.6b | €580.4m | -€885,027,295.30 | 13.4x | -14.2x | 21.7x |
| Mon, 02 Mar 2026 | €11.5b | €559.2m | -€762,693,409.86 | 13.7x | -15.1x | 20.6x |
| Wed, 28 Jan 2026 | €11.3b | €558.4m | -€761,246,656.73 | 13.9x | -14.8x | 20.2x |
| Fri, 26 Dec 2025 | €12.2b | €641.2m | -€693,420,343.93 | 10.1x | -17.5x | 19x |
| Sun, 23 Nov 2025 | €2.5b | €637.7m | -€432,304,925.78 | 10.6x | -5.7x | 3.9x |
| Tue, 21 Oct 2025 | €2.5b | €645.0m | -€429,553,352.68 | 10.2x | -5.8x | 3.9x |
| Thu, 18 Sep 2025 | €2.5b | €674.5m | -€469,646,941.73 | 14x | -5.3x | 3.7x |
| Sat, 16 Aug 2025 | €2.6b | €673.9m | -€445,361,747.38 | 15.4x | -5.8x | 3.8x |
| Mon, 14 Jul 2025 | €1.9b | €655.9m | -€452,570,328.54 | 16.5x | -4.2x | 2.9x |
| Wed, 11 Jun 2025 | €2.1b | €667.6m | -€497,924,000.91 | 17.6x | -4.1x | 3.1x |
| Fri, 09 May 2025 | €2.5b | €670.4m | -€663,582,354.29 | 39.4x | -3.7x | 3.7x |
| Sun, 06 Apr 2025 | €2.1b | €652.8m | -€554,552,238.32 | 13.3x | -3.8x | 3.2x |
| Tue, 04 Mar 2025 | €2.5b | €649.9m | -€525,473,296.86 | 16.5x | -4.7x | 3.8x |
| Thu, 30 Jan 2025 | €2.3b | €649.9m | -€526,209,588.35 | 16x | -4.4x | 3.6x |
| Sat, 28 Dec 2024 | €2.3b | €653.7m | -€543,855,569.26 | 17.4x | -4.3x | 3.6x |
| Mon, 25 Nov 2024 | €2.5b | €654.8m | -€549,916,932.35 | 18x | -4.5x | 3.8x |
| Wed, 23 Oct 2024 | €2.9b | €627.9m | -€519,789,292.20 | 19.1x | -5.5x | 4.5x |
| Fri, 20 Sep 2024 | €3.0b | €497.5m | -€636,892,933.08 | 36.8x | -4.7x | 6x |
| Sun, 18 Aug 2024 | €3.0b | €520.5m | -€580,633,559.54 | 37x | -5.2x | 5.8x |
| Tue, 16 Jul 2024 | €3.0b | €511.7m | -€566,230,666.34 | 29.3x | -5.3x | 5.9x |
| Thu, 13 Jun 2024 | €3.3b | €509.8m | -€565,187,551.42 | 28x | -5.9x | 6.5x |
| Sat, 11 May 2024 | €3.2b | €502.8m | -€593,891,697.18 | 27.7x | -5.4x | 6.4x |
| Mon, 08 Apr 2024 | €3.2b | €511.5m | -€567,567,497.12 | 22.2x | -5.7x | 6.3x |
| Wed, 06 Mar 2024 | €3.1b | €558.7m | -€673,698,817.44 | 21.6x | -4.5x | 5.5x |
| Fri, 02 Feb 2024 | €3.2b | €594.5m | -€684,633,851.00 | 21.9x | -4.6x | 5.3x |
| Sun, 31 Dec 2023 | €3.2b | €594.0m | -€681,719,515.00 | 23.4x | -4.7x | 5.4x |
| Tue, 28 Nov 2023 | €3.2b | €594.2m | -€683,204,417.00 | 22.3x | -4.6x | 5.3x |
| Thu, 26 Oct 2023 | €3.0b | €804.1m | -€566,820,795.00 | 21.2x | -5.3x | 3.7x |
| Sat, 23 Sep 2023 | €3.7b | €873.4m | -€616,043,185.00 | 25.9x | -6.1x | 4.3x |
| Mon, 21 Aug 2023 | €3.6b | €818.1m | -€726,312,722.00 | 23.6x | -5x | 4.5x |
| Wed, 19 Jul 2023 | €3.7b | €817.1m | -€732,042,878.00 | 25.6x | -5.1x | 4.6x |
| Fri, 16 Jun 2023 | €3.8b | €820.2m | -€741,411,025.00 | 25.5x | -5.1x | 4.6x |
| Sun, 14 May 2023 | €3.7b | €831.4m | -€760,840,682.00 | 25.3x | -4.9x | 4.5x |
| Tue, 11 Apr 2023 | €3.5b | €946.3m | -€698,522,243.00 | 18.5x | -5x | 3.7x |
Price to Earnings Ratio
-5x
Current Industry PE
- Investors are optimistic on the French Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 6.0x is lower than the industry's current PS ratio of 20.5x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 17% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does French Biotech compare with similar industries?
| FR Market | 3.49% | |
| Healthcare | 1.24% | |
| Biotech | 9.47% | |
| Biotech | 9.47% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | €101.40 | 13.7% +€966.1m | 1,928.0% | PS1757x | |
| NANO Nanobiotix | €27.40 | 3.4% +€43.6m | 826.9% | PS40.7x | |
| ALSEN Sensorion | €0.42 | 17.4% +€31.9m | 7.7% | PS37x | |
| DBV DBV Technologies | €3.64 | 2.7% +€26.4m | 189.0% | PS206.6x | |
| ALCLS Cellectis | €3.11 | 10.5% +€21.4m | 182.3% | PS3.3x |
